China Cuts U.S. Soybean Imports by More Than 80% as Tariffs Bite
(Bloomberg) -- China, the world's biggest soybean importer, cut shipments of the oilseed from the U.S. by more than 80 percent in September from a year earlier as retaliatory tariffs imposed as part of the ongoing trade war between the world's top two economies take their toll.
Inbound cargoes from the U.S. plunged to 132,000 metric tons from 937,000 tons in the same month last year, Bloomberg calculations based on customs data show. China published a country breakdown of imports for the first time since March. The U.S. loss was Brazil's gain as the world's top soybean exporter boosted shipments 28 percent to 7.59 million tons, the data show.
China imported the smallest volume of soybeans for September in two years and inbound cargoes in the fourth quarter are set to slump 17 percent from a year earlier to 20 million tons as the country shuns U.S. soybeans that incur a 25 percent tariff, said the China National Grain and Oils Information Center.
Low imports by China will lead U.S. farmers to build up an historically high level of soybean inventories that will carry through until next year, Soren Schroder, chief executive officer of Bunge Ltd., said in an interview Wednesday.
To contact Bloomberg News staff for this story: Niu Shuping in Beijing at nshuping@bloomberg.net
To contact the editors responsible for this story: Anna Kitanaka at akitanaka@bloomberg.net, James Poole
©2018 Bloomberg L.P.
With assistance from Editorial Board
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.